NG Bio Ltd Overview
NG Bio Ltd is an early-stage investor and venture builder focused on extending health span by addressing immune responses that contribute to major human diseases. The company collaborates with pharmaceutical companies and co-investors to enhance its investments in the life sciences sector.
Is NG Bio Ltd the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with NG Bio Ltd, along with a list of other relevant VCs, is available on Hopohopo.io.
NG Bio Ltd
Investment focus
Invest in
- Western Europe 1 / 14
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- PharmaTech
Stages
Seed
First ticket size
£500,000 - £10,000,000
How to approach funds like NG Bio Ltd
When approaching NG Bio Ltd, founders should highlight novel scientific approaches or platforms that target immune modulation with clear translational potential. Demonstrate a strong understanding of the clinical and commercial pathways for your technology, and be prepared to discuss how strategic partnerships with pharma or co-investors could accelerate development. NG Bio values teams with deep domain expertise and a track record of navigating early-stage biotech challenges.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
